FN1 and systemic sclerosis: END55 treatment of human fibrotic lung cores significantly reduced the hydroxyproline content of IPF and SSc lung tissues (Figure 6C), as well as the gene expression of fibronectin, collagen 1A1, and collagen 1A2 (Figure 6D).